Skip to main content

Advertisement

Log in

Characteristics of Multifocal and Multicentric Breast Cancers

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Multifocality and multicentricity are increasingly recognized in breast cancer. However, little is known about the characteristics and biology of these cancers and the clinical implications are controversial.

Methods

A retrospective, institutional database was used to compare characteristics of multifocal (MF) and multicentric (MC) breast cancers with unifocal (UF) cancers to study concordance of histology and receptor status among primary and secondary foci and to evaluate predictors of lymph node positivity using multivariate logistic regression.

Results

Of 1495 invasive cancers, 1231 (82.3 %) were UF, 169 (11.3 %) were MF, and 95 (6.4 %) were MC cancers. When MF and MC cancers were compared with UF cancers, MC but not MF cancers were associated with young age at diagnosis, larger tumor size, lymphovascular invasion, and node positivity. MF but not MC tumors were more likely to be ER/PR+Her2+ tumors and less likely to be triple-negative cancers compared with UF tumors. MF tumors were more likely to be infiltrating ductal carcinomas with an extensive intraductal component, and MC tumors were more likely to be infiltrating lobular carcinomas. Concordance of histology and receptor status between primary and secondary foci was high and was similar for both MF and MC cancers. Multicentricity remained an independent predictor of lymph node positivity on multivariate analysis.

Conclusion

MF and MC tumors seem to be biologically different diseases. MC is clinicopathologically more aggressive than MF disease and is more frequently associated with younger age and larger tumor size and also is an independent predictor of node positivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cheatle G. Benign and malignant changes in duct epithelium of the breast. Br J Cancer. 1920;8(31):285–306.

    Google Scholar 

  2. Qualheim RE, Gall EA. Breast carcinoma with multiple sites of origin. Cancer. 1957;10(3):460–8.

    Article  CAS  PubMed  Google Scholar 

  3. Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008;26(19):3248–58.

    Article  PubMed  Google Scholar 

  4. Sardanelli F, Giuseppetti GM, Panizza P, et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol. 2004;183(4):1149–57.

    Article  PubMed  Google Scholar 

  5. Girardi V, Carbognin G, Camera L, et al. Multifocal, multicentric and contralateral breast cancers: breast MR imaging in the preoperative evaluation of patients with newly diagnosed breast cancer. Radiol Med. 2011;116(8):1226–38.

    Article  CAS  PubMed  Google Scholar 

  6. Jain S, Rezo A, Shadbolt B, Dahlstrom JE. Synchronous multiple ipsilateral breast cancers: implications for patient management. Pathology. 2009;41(1):57–67.

    Article  PubMed  Google Scholar 

  7. Bendifallah S, Werkoff G, Borie-Moutafoff C, et al. Multiple synchronous (multifocal and multicentric) breast cancer: clinical implications. Surg Oncol. 2010;19(4):e115–23.

    Article  PubMed  Google Scholar 

  8. Yerushalmi R, Tyldesley S, Woods R, Kennecke HF, Speers C, Gelmon KA. Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality? Ann Oncol. 2012;23(4):876–81.

    Article  CAS  PubMed  Google Scholar 

  9. Ustaalioglu BO, Bilici A, Kefeli U, et al. The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: single center experience. Am J Clin Oncol. 2012;35(6):580–6.

    Article  PubMed  Google Scholar 

  10. Weissenbacher TM, Zschage M, Janni W, et al. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified? Breast Cancer Res Treat. 2010;122(1):27–34.

    Article  CAS  PubMed  Google Scholar 

  11. Oh JL, Dryden MJ, Woodward WA, et al. Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy. J Clin Oncol. 2006;24(31):4971–5.

    Article  PubMed  Google Scholar 

  12. Wolters R, Wockel A, Janni W, et al. Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients. Breast Cancer Res Treat. 2013;142(3):579–90.

    Article  CAS  PubMed  Google Scholar 

  13. Lynch SP, Lei X, Chavez-MacGregor M, et al. Multifocality and multicentricity in breast cancer and survival outcomes. Ann Oncol. 2012;23(12):3063–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Katz A, Strom EA, Buchholz TA, Theriault R, Singletary SE, McNeese MD. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys. 2001;50(3):735–42.

    Article  CAS  PubMed  Google Scholar 

  15. Rezo A, Dahlstrom J, Shadbolt B, et al. Tumor size and survival in multicentric and multifocal breast cancer. Breast. 2011;20(3):259–63.

    Article  PubMed  Google Scholar 

  16. Cabioglu N, Ozmen V, Kaya H, et al. Increased lymph node positivity in multifocal and multicentric breast cancer. J Am Coll Surg. 2009;208(1):67–74.

    Article  PubMed  Google Scholar 

  17. Chua B, Ung O, Taylor R, Boyages J. Frequency and predictors of axillary lymph node metastases in invasive breast cancer. ANZ J Surg. 2001;71(12):723–8.

    Article  CAS  PubMed  Google Scholar 

  18. Edge S. AJCC cancer staging manual. New York: Springer; 2010.

    Google Scholar 

  19. Andea AA, Wallis T, Newman LA, Bouwman D, Dey J, Visscher DW. Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma. Cancer. 2002;94(5):1383–90.

    Article  PubMed  Google Scholar 

  20. Coombs NJ, Boyages J. Multifocal and multicentric breast cancer: does each focus matter? J Clin Oncol. 2005;23(30):7497–502.

    Article  PubMed  Google Scholar 

  21. Boyages J, Jayasinghe UW, Coombs N. Multifocal breast cancer and survival: each focus does matter particularly for larger tumours. Eur J Cancer. 2010;46(11):1990–6.

    Article  PubMed  Google Scholar 

  22. O’Daly BJ, Sweeney KJ, Ridgway PF, et al. The accuracy of combined versus largest diameter in staging multifocal breast cancer. J Am Coll Surg. 2007;204(2):282–5.

    Article  PubMed  Google Scholar 

  23. Hilton JF, Bouganim N, Dong B, et al. Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: an analysis of the NCIC CTG MA.5 and MA.12 clinical trials. Breast Cancer Res Treat. 2013;142(1):143–51.

    Article  CAS  PubMed  Google Scholar 

  24. Dawson PJ, Baekey PA, Clark RA. Mechanisms of multifocal breast cancer: an immunocytochemical study. Hum Pathol. 1995;26(9):965–9.

    Article  CAS  PubMed  Google Scholar 

  25. Teixeira MR, Ribeiro FR, Torres L, et al. Assessment of clonal relationships in ipsilateral and bilateral multiple breast carcinomas by comparative genomic hybridisation and hierarchical clustering analysis. Br J Cancer. 2004;91(4):775–82.

    CAS  PubMed Central  PubMed  Google Scholar 

  26. Eeles R, Knee G, Jhavar S, et al. Multicentric breast cancer: clonality and prognostic studies. Breast Cancer Res Treat. 2011;129(3):703–16.

    Article  CAS  PubMed  Google Scholar 

  27. Middleton LP, Vlastos G, Mirza NQ, Eva S, Sahin AA. Multicentric mammary carcinoma: evidence of monoclonal proliferation. Cancer. 2002;94(7):1910–6.

    Article  PubMed  Google Scholar 

  28. Choi Y, Kim EJ, Seol H, et al. The hormone receptor, human epidermal growth factor receptor 2, and molecular subtype status of individual tumor foci in multifocal/multicentric invasive ductal carcinoma of breast. Hum Pathol. 2012;43(1):48–55.

    Article  CAS  PubMed  Google Scholar 

  29. Buggi F, Folli S, Curcio A, et al. Multicentric/multifocal breast cancer with a single histotype: is the biological characterization of all individual foci justified? Ann Oncol. 2012;23(8):2042–6.

    Article  CAS  PubMed  Google Scholar 

  30. Pekar G, Gere M, Tarjan M, Hellberg D, Tot T. Molecular phenotype of the foci in multifocal invasive breast carcinomas: intertumoral heterogeneity is related to shorter survival and may influence the choice of therapy. Cancer. 2014;120(1):26–34.

    Article  PubMed  Google Scholar 

  31. Boros M, Marian C, Moldovan C, Stolnicu S. Morphological heterogeneity of the simultaneous ipsilateral invasive tumor foci in breast carcinoma: a retrospective study of 418 cases of carcinomas. Pathol Res Pract. 2012;208(10):604–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Donald R. Lannin MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kanumuri, P., Hayse, B., Killelea, B.K. et al. Characteristics of Multifocal and Multicentric Breast Cancers. Ann Surg Oncol 22, 2475–2482 (2015). https://doi.org/10.1245/s10434-015-4430-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-015-4430-6

Keywords

Navigation